Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients-Reference-Cited by-同舟云学术

Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients

Published:2016-08-23 Issue:8 Volume:44 Page:846-855
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lin D.¹,Yang H.-I.²³,Nguyen N.⁴⁵,Hoang J.⁴,Kim Y.⁴,Vu V.⁴,Le A.⁴,Chaung K.⁴⁶,Nguyen V.⁴⁶,Trinh H.⁷,Li J.⁸,Zhang J.⁹,Hsing A.¹⁰¹¹,Chen C.-J.²¹²,Nguyen M. H.⁴

Affiliation:

1. Department of Medicine; Stanford University Medical Center; Palo Alto CA USA

2. Genomics Research Center; Academia Sinica; Taipei Taiwan

3. Institute of Clinical Medicine; National Yang-Ming University; Taipei Taiwan

4. Division of Gastroenterology and Hepatology; Stanford University Medical Center; Palo Alto CA USA

5. Department of Medicine; University of California San Diego; San Diego CA USA

6. Pacific Health Foundation; San Jose CA USA

7. San Jose Gastroenterology; San Jose CA USA

8. Mountain View Division; Palo Alto Medical Foundation; Mountain View CA USA

9. Chinese Hospital; San Francisco CA USA

10. Stanford Cancer Institute; Stanford School of Medicine; Palo Alto CA USA

11. Health Research and Policy Department; Stanford School of Medicine; Standford CA USA

12. Graduate Institute of Epidemiology and Preventive Medicine; National Taiwan University; Taipei Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13774/fullpdf

Reference38 articles.

1. Estimations of worldwide prevalence of hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection;Weinbaum;MMWR Recomm Rep,2008

3. Hepatitis B in the United States: a major health disparity affecting many foreign-born populations;Ward;Hepatology,2012

4. Hepatitis B e antigen and the risk of hepatocellular carcinoma;Yang;N Engl J Med,2002

5. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B;Yuen;J Hepatol,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines;Vaccines;2024-08-21

2. Sex and ethnic disparities in hepatitis B evaluation and treatment across the world;Journal of Hepatology;2024-07

3. Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase;European Journal of Medical Research;2024-06-21

4. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma;World Journal of Gastrointestinal Surgery;2024-03-27

5. Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels;iLABMED;2023-10-29